Home
Axis Biotec Brasil

Axis Biotec Brasil Market Share Analysis for May 2026

Biotechnology hub: Silvestre Labs, Cryopraxis, CellPraxis and BioNK. Cryopreservation, bioprocesses, advanced therapies and NK cell immunotherapy.

Industry: N/A

Domainaxisbiotec.com.br

Year Founded1984

Employees201 - 500

Annual Revenue--

Axis Biotec Brasil

Axis Biotec Brasil (including company regionals)

axisbiotec.com.br

See more website traffic and engagement information

Total visits to Axis Biotec Brasil's top domains

Understand Axis Biotec Brasil market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Axis Biotec Brasil's top domains

Analyze Axis Biotec Brasil engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Axis Biotec Brasil's top domains

See how Axis Biotec Brasil keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Axis Biotec Brasil top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Axis Biotec Brasil

These are the website technologies, by industry, used by Axis Biotec Brasil top domains

Social (2)

Instagram

Conversion & Analytics (1)

Google Analytics

Email Services (1)

Microsoft Exchange Online

Mobile (1)

Meta Viewport

More Technologies

1

See all

News & Signals from Axis Biotec Brasil

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPlantForm Corporation partnered with Axisbiotec on Jan 1st '17.Furthermore, in 2017, PlantForm Corporation, in partnership with Brazil-based Axis Biotec Brasil, launched a new joint venture, which included a new facility consisting of a biopharmaceutical lab and pilot production facility in Rio de Janeiro.

NewsAxisbiotec expands facilities to Brazil, South America, Americas.Axis Biotec announces the construction of an innovative tobacco-based biopharmaceutical expression and pilot manufacturing facility in Brazil.